Home Carbonyls Cyclopentaneacetamide, N-[(1S)-4-[(aminoiminomethyl)amino]-1-[[[2-(3,5-dioxo-1,2-diphenyl-1,2,4-triazolidin-4-yl)ethyl]amino]carbonyl]butyl]-1-[2-[4-(6,11-dihydro-6-oxo-5H-dibenz[b,e]azepin-11-yl)-1-piperazinyl]-2-oxoethyl]-

Cyclopentaneacetamide, N-[(1S)-4-[(aminoiminomethyl)amino]-1-[[[2-(3,5-dioxo-1,2-diphenyl-1,2,4-triazolidin-4-yl)ethyl]amino]carbonyl]butyl]-1-[2-[4-(6,11-dihydro-6-oxo-5H-dibenz[b,e]azepin-11-yl)-1-piperazinyl]-2-oxoethyl]-

CAS No.:
246146-55-4
Catalog Number:
AG002OSD
Molecular Formula:
C49H57N11O6
Molecular Weight:
896.0470
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1mg
99%
1 week
United States
$348
- +
Product Description
Catalog Number:
AG002OSD
Chemical Name:
Cyclopentaneacetamide, N-[(1S)-4-[(aminoiminomethyl)amino]-1-[[[2-(3,5-dioxo-1,2-diphenyl-1,2,4-triazolidin-4-yl)ethyl]amino]carbonyl]butyl]-1-[2-[4-(6,11-dihydro-6-oxo-5H-dibenz[b,e]azepin-11-yl)-1-piperazinyl]-2-oxoethyl]-
CAS Number:
246146-55-4
Molecular Formula:
C49H57N11O6
Molecular Weight:
896.0470
MDL Number:
MFCD09878236
IUPAC Name:
(2S)-5-(diaminomethylideneamino)-N-[2-(3,5-dioxo-1,2-diphenyl-1,2,4-triazolidin-4-yl)ethyl]-2-[[2-[1-[2-oxo-2-[4-(6-oxo-5,11-dihydrobenzo[c][1]benzazepin-11-yl)piperazin-1-yl]ethyl]cyclopentyl]acetyl]amino]pentanamide
InChI:
InChI=1S/C49H57N11O6/c50-46(51)53-25-13-22-40(45(64)52-26-27-58-47(65)59(34-14-3-1-4-15-34)60(48(58)66)35-16-5-2-6-17-35)54-41(61)32-49(23-11-12-24-49)33-42(62)56-28-30-57(31-29-56)43-36-18-7-8-19-37(36)44(63)55-39-21-10-9-20-38(39)43/h1-10,14-21,40,43H,11-13,22-33H2,(H,52,64)(H,54,61)(H,55,63)(H4,50,51,53)/t40-,43?/m0/s1
InChI Key:
RSJAXPUYVJKAAA-JPGJPTAESA-N
SMILES:
NN=CNCCC[C@@H](C(=O)NCCn1c(=O)n(n(c1=O)c1ccccc1)c1ccccc1)NC(=O)CC1(CCCC1)CC(=O)N1CCN(CC1)C1c2ccccc2NC(=O)c2c1cccc2
Properties
Complexity:
1710  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0
Exact Mass:
895.449g/mol
Formal Charge:
0
Heavy Atom Count:
66  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
5  
Isotope Atom Count:
0
Molecular Weight:
896.066g/mol
Monoisotopic Mass:
895.449g/mol
Rotatable Bond Count:
16  
Topological Polar Surface Area:
219A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
3.8  
Literature
Title Journal
Anorexia induction by the trichothecene deoxynivalenol (vomitoxin) is mediated by the release of the gut satiety hormone peptide YY. Toxicological sciences : an official journal of the Society of Toxicology 20121201
A role for neuropeptide Y in the gender-specific gastrointestinal, corticosterone and feeding responses to stress. British journal of pharmacology 20120801
Role of Y(2) receptors in the regulation of gastric tone in rats. American journal of physiology. Gastrointestinal and liver physiology 20120401
Role of neuropeptide Y Y₁ and Y₂ receptors on behavioral despair in a rat model of depression with co-morbid anxiety. Neuropharmacology 20120101
Distinct effects of NPY13-36, a specific NPY Y2 agonist, in a model of rodent endotoxemia on leukocyte subsets and cytokine levels. Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft 20111220
Attenuation of pain-related behavior evoked by injury through blockade of neuropeptide Y Y2 receptor. Pain 20110501
High expression of NPY receptors in the human testis. Molecular and cellular endocrinology 20110430
Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy. Oncogene 20101014
Mutagenesis of human neuropeptide Y/peptide YY receptor Y2 reveals additional differences to Y1 in interactions with highly conserved ligand positions. Regulatory peptides 20100809
Selective and brain penetrant neuropeptide y y2 receptor antagonists discovered by whole-cell high-throughput screening. Molecular pharmacology 20100101
Peripheral peptide YY inhibits propulsive colonic motor function through Y2 receptor in conscious mice. American journal of physiology. Gastrointestinal and liver physiology 20100101
Effect of pharmacological manipulations of neuropeptide Y and corticotropin-releasing factor neurotransmission on incubation of conditioned fear. Neuroscience 20091229
The identification and optimisation of novel and selective diamide neuropeptide Y Y2 receptor antagonists. Bioorganic & medicinal chemistry letters 20090801
Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer's disease. The Journal of neuroscience : the official journal of the Society for Neuroscience 20090128
Different regulation of atrial ANP release through neuropeptide Y2 and Y4 receptors. Journal of Korean medical science 20081201
Activity-dependent volume transmission by transgene NPY attenuates glutamate release and LTP in the subiculum. Molecular and cellular neurosciences 20081001
Endogenous PYY and NPY mediate tonic Y1- and Y2-mediated absorption in human and mouse colon. Nutrition (Burbank, Los Angeles County, Calif.) 20080901
Neuropeptide Y receptors in primary human brain tumors: overexpression in high-grade tumors. Journal of neuropathology and experimental neurology 20080801
Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway. Journal of molecular and cellular cardiology 20080301
Role of CCK1 and Y2 receptors in activation of hindbrain neurons induced by intragastric administration of bitter taste receptor ligands. American journal of physiology. Regulatory, integrative and comparative physiology 20080101
NPY gene transfer in the hippocampus attenuates synaptic plasticity and learning. Hippocampus 20080101
Oligomerization of neuropeptide Y (NPY) Y2 receptors in CHO cells depends on functional pertussis toxin-sensitive G-proteins. Regulatory peptides 20071204
Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y. The European journal of neuroscience 20071201
A novel long-acting selective neuropeptide Y2 receptor polyethylene glycol-conjugated peptide agonist reduces food intake and body weight and improves glucose metabolism in rodents. The Journal of pharmacology and experimental therapeutics 20071101
Selective role of neuropeptide Y receptor subtype Y2 in the control of gonadotropin secretion in the rat. American journal of physiology. Endocrinology and metabolism 20071101
Neuropeptide Y-induced enhancement of the evoked release of newly synthesized dopamine in rat striatum: mediation by Y2 receptors. Neuropharmacology 20070501
Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor. Hippocampus 20070101
Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: Correlation with Y2 receptor plasticity. Neuroscience 20061228
Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands. European journal of pharmacology 20061203
Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze. Peptides 20061201
Ventricular fibrillation induced by ischemia-reperfusion is not prevented by the NPY Y2 receptor antagonist BIIE0246. Journal of cardiovascular pharmacology and therapeutics 20060901
Neuropeptide Y2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats. British journal of pharmacology 20060701
Irreversible binding kinetics of neuropeptide Y ligands to Y2 but not to Y1 and Y5 receptors. Pharmacology 20051201
Neuropeptide Y bioavailability is suppressed in the hindlimb of female Sprague-Dawley rats. The Journal of physiology 20051015
Influence of endogenous neuropeptide Y (NPY) on the sympathetic-parasympathetic interaction in the canine heart. Journal of cardiovascular pharmacology 20051001
The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors. The European journal of neuroscience 20050901
Intravenous peptide YY3-36 and Y2 receptor antagonism in the rat: effects on feeding behaviour. Journal of neuroendocrinology 20050701
Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake. Brain research 20050510
Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence. Neuroscience letters 20050227
Spontaneous release of neuropeptide Y tonically inhibits recurrent mossy fiber synaptic transmission in epileptic brain. The Journal of neuroscience : the official journal of the Society for Neuroscience 20050216
Differential expression of Y receptors and signaling pathways in intestinal circular and longitudinal smooth muscle. Regulatory peptides 20050215
Endogenous neuropeptide Y depresses the afferent signaling of gastric acid challenge to the mouse brainstem via neuropeptide Y type Y2 and Y4 receptors. Neuroscience 20050101
Neuropeptide Y inhibits acetylcholine release in human heart atrium by activation of Y2-receptors. Naunyn-Schmiedeberg's archives of pharmacology 20040501
Involvement of peripheral neuropeptide Y receptors in sympathetic modulation of acute cutaneous flare induced by intradermal capsaicin. Neuroscience 20040101
Stimulation of neurons in rat ARC inhibits gastric acid secretion via hypothalamic CRF1/2- and NPY-Y1 receptors. American journal of physiology. Gastrointestinal and liver physiology 20031201
Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1-17, Ala31, Aib32]NPY. British journal of pharmacology 20030801
Functional consequences of neuropeptide Y Y 2 receptor knockout and Y2 antagonism in mouse and human colonic tissues. British journal of pharmacology 20030601
Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus. Neuropharmacology 20030201
Selective mediation of nerve injury-induced tactile hypersensitivity by neuropeptide Y. The Journal of neuroscience : the official journal of the Society for Neuroscience 20021115
Blockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration in rats. Neuroscience letters 20021025
Blockade of neuropeptide Y(2) receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246. British journal of pharmacology 20020601
Antagonistic interaction between BIIE 0246, a neuropeptide Y Y2-receptor antagonist, and omega-conotoxin GVIA, a Ca2+ channel antagonist, in presynaptic transmitter releases in dog splenic arteries. Japanese journal of pharmacology 20020601
Reciprocal mutations of neuropeptide Y receptor Y2 in human and chicken identify amino acids important for antagonist binding. FEBS letters 20020508
The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020501
Neuropeptide Y inhibits double peaked vasoconstrictor responses to periarterial nerve stimulation primarily through prejunctional Y2 receptor subtype in canine splenic arteries. Autonomic & autacoid pharmacology 20020401
Autoinhibitory function of the sympathetic prejunctional neuropeptide Y Y(2) receptor evidenced by BIIE0246. European journal of pharmacology 20020329
Role of neuropeptide Y Y(2) receptors in modulation of cardiac parasympathetic neurotransmission. Regulatory peptides 20020215
Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo. Naunyn-Schmiedeberg's archives of pharmacology 20020201
Brain neuropeptide Y (NPY) in stress and alcohol dependence. Reviews in the neurosciences 20020101
Involvement of NPY Y2 receptor subtype in the control of the spontaneous NO/GnRH release at the rat median eminence. Neuroreport 20011029
Existence of both neuropeptide Y, Y1 and Y2 receptors in pig spleen: evidence using subtype-selective antagonists in vivo. Life sciences 20010914
Vascular pharmacology of BIIE0246, the first selective non-peptide neuropeptide Y Y(2) receptor antagonist, in vivo. British journal of pharmacology 20010801
The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y(2) receptor: pharmacological evidence and molecular cloning. Molecular pharmacology 20010701
Effects of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246, on Y2 receptors at peripheral neuroeffector junctions. British journal of pharmacology 20010201
BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist. European journal of pharmacology 19991119
Properties